Access 45,000+ medical specialists, key opinion leaders, clinical pharmacists, payors, and niche patient panels across 35+ countries. Rigorously verified via licensing board matches and manual screening calls.
Pre-profiled, verified, and segmented lists of healthcare providers mapped by clinical activity, hospital type, and sub-specialty.
3,200+ interventional cardiologists, electrophysiologists, and cardiac surgeons with hospital affiliation tracking.
2,850+ medical, surgical, and radiation oncologists double-verified via therapeutic caseload surveys.
4,100+ clinical neurologists and child/adolescent psychiatrists mapped across major urban health clusters.
1,900+ endocrinologists pre-profiled with caseload incidence rates for Type-1 and Type-2 clinical trackers.
15,000+ primary care physicians in private, group, and community hospital practices in North America and Europe.
5,400+ clinical pharmacists, formulary managers, and health insurance payors providing policy development insight.
Healthcare policy and therapeutic studies require absolute authority. We bypass standard marketing-based panel recruitment, deploying a 3-layer professional vetting pipeline.
A Top-10 BioPharma organization needed to consult hospital pharmacy directors regarding biosimilar formulary switches. Scrutiny Global delivered 120 verified formulary decision-makers in 4 countries within 72 hours, maintaining a 96% completion rate.
Provide your specialty criteria, geographic filters, incidence projections, and length of interview (LOI). Our healthcare sample architects will provide detailed feasibility counts and customized pricing grids.
We have specialized consumer panels matching 45+ chronic disease profiles (e.g., oncology sufferers, autoimmune, cardiovascular ailments) fully consented and managed under GDPR/HIPAA protocols.